Insider trade

Officer received an award of 2,020 LH derivative securities

Traded Feb 10, 2026 · Filed Feb 12, 2026

LabcorpLH

2,020
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 10, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 12, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000920148-26-000060
Filed / recorded

Feb 12, 2026, 8:32 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

LABCORP HOLDINGS INC.

Issuer CIK

920148

Ticker

LH

Reporting person

Brian J Caveney

Relationship

Officer

Officer title

EVP, Pres of ED, CMO & CSO

Security

Restricted Stock Unit

Table

Derivative (Table II)

Transaction date

Feb 10, 2026

Transaction code

A

Shares / units

2,020

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

4,910

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.
This number reflects the aggregate number of Restricted Stock Units held by the reporting person.